TLDR Temporary hair loss can occur after 5-fluorouracil treatment for keloids.
The document reported a case of transient chemotherapy-induced alopecia in a 58-year-old man after intralesional 5-fluorouracil treatment for keloids. The patient experienced temporary hair loss in the beard area surrounding the treated keloids, which regrew several weeks after the treatment. This side effect had not been previously documented for localized intralesional chemotherapy for keloids. The study highlighted the importance of dermatologists being aware of this potential side effect and counseling patients accordingly.
218 citations
,
January 2013 in “The Lancet Oncology” Chemotherapy causes hair loss by damaging hair follicles and stem cells, with more research needed for prevention and treatment.
May 2005 in “Journal of the American Academy of Dermatology” April 2024 in “International journal of molecular sciences” Light-based treatment, Photobiomodulation, shows promise for non-invasive skin therapy with few side effects.
67 citations
,
January 2022 in “Theranostics” Advanced nanocarrier and microneedle drug delivery methods are more effective, safer, and less invasive for treating skin diseases.
4 citations
,
March 2009 in “British Journal of Dermatology” The conference highlighted new dermatological treatments and emphasized early intervention and addressing conditions lacking evidence-based treatments.
1 citations
,
November 2014 The document explains hair and nail biology, common hair loss conditions and treatments, oral and genital skin diseases, and the risks and treatments associated with squamous cell carcinoma.
